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 2 
SUMMARY 32 
 
Purpose: Longitudinal data arises when repeated measurements are taken on the same 34 
individuals over time. Inference about between group differences of within-subject change 
is usually of interest. This statistical primer for cardiothoracic and vascular surgeons aims to 36 
provide a short and practical introduction of biostatistical methods on how to analyse 
repeated measures data. 38 
 
Methods: Several methodological approaches for analysing repeated measures will be 40 
introduced, ranging from simple approaches to advanced regression modelling. Design 
considerations of studies involving repeated measures are discussed and the methods 42 
illustrated with a dataset measuring coronary sinus potassium in dogs after occlusion. 
 44 
Conclusion: Cardiothoracic and vascular surgeons should be aware of the myriad of 
approaches available to them for analysing repeated measures data, including the relative 46 
merits and disadvantages of each. It is important to present effective graphical displays of 
the data, and to avoid arbitrary cross-sectional statistical comparisons. 48 
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INTRODUCTION 
Repeated measures data—also known as longitudinal data and serial measures 54 
data—are routinely analysed in many studies [1]. The data can be collected both 
prospectively and retrospectively, allowing for changes over time and its variability within 56 
individuals to be distinguished; for example, echocardiographic measurements recorded at 
different follow-up times after allograft implantation, or Interleukin-6 measured in rats at 58 
pre-specified times following cardiopulmonary bypass. The guidelines for reporting 
mortality and morbidity after cardiac valve interventions also propose the use of 60 
longitudinal data analysis for repeated measurement data in patient undergoing 
cardiovascular surgery [2]. 62 
The focus of this Statistical Primer will be on measurements repeatedly recorded 
over time, although repeated measures can occur in other circumstances, for example when 64 
the conditions are changed (e.g. treatment) and the same patients are measured under 
each experimental condition. Unlike measurements taken on different patients, repeated 66 
measures data, however, are not independent. In other words, repeated observations on 
the same individual will be more similar to each other than to observations on other 68 
individuals. This necessitates statistical methodology that can account for this dependency. 
 70 
DESIGN CONSIDERATIONS 
Balanced versus unbalanced data 72 
When subjects are measured at a fixed number of time points that are common to 
all subjects, then the data are said to be balanced. For example, rats might be tested at 74 
times 0, 2-hours, 6-hours, 12-hours, and 24-hours. In some designed studies, these 
measurements may be mistimed, e.g. in human studies where patients are delayed 76 
returning to clinic for scheduled follow-up appointments. In some observational studies, i.e. 
naturalistic cohort studies, measurement times will often vary between subjects and can 78 
vary substantially in the number of measurements recorded. Moreover, the patients may 
have different durations of follow-up observation for various reasons, and may be censored 80 
due to terminal events. This would be classed as unbalanced data, and precludes the use of 
certain statistical methodologies. For balanced and unbalanced measurements, the datasets 82 
are often stored in so-called ‘wide format’ (Table S1a) and ‘long format’ (Table S1b), 
respectively.  84 
 4 
Missing data 
Missing data are not uncommon in longitudinal outcome studies. For example, if a 86 
patient fails to attend a scheduled appointment, then measurements cannot be taken, and 
the observation is deemed missing or incomplete. Approaches to handling missing data 88 
include complete-case analysis, i.e. deleting patients with one or more missing 
measurement values; last observation carried forward (LOCF) or interpolation methods; and 90 
other imputation techniques. Assumptions about the mechanism leading to missing data 
dictates the appropriateness of different techniques; however, in general it is widely 92 
accepted that simple techniques such as complete-case analysis and LCOF lead to serious 
bias, and therefore should be avoided. Alternative methods are discussed elsewhere [3]. 94 
 
METHODOLOGY 96 
Two-stage methods 
For balanced data, the comparison of treatments might be done by performing 98 
separate statistical tests at each time point (Figure 2A). However, this approach is 
inappropriate as it often fails to address relevant research questions and is subject to 100 
statistical deficiencies such as ignoring that observations on a given subject are likely to be 
correlated, and multiple testing [4]. Additionally, the accompanying presentation is 102 
frequently inadequate [5], as illustrated in the example shown in Figure 2A. One alternative 
approach is to reduce the data for each subject to a single meaningful statistic, which are 104 
then analysed using standard methods for independent groups, e.g. the independent 
samples t-test [4]. The choice of statistic will depend on the data and the study question, in 106 
particular whether the data display a growth-like pattern or a peaked-like pattern; see Table 
S2 for examples. Even when not used for the primary analysis, such reduced data summary 108 
statistics can be useful, yet it must still be recognised that there might be some information 
loss with this approach. 110 
Repeated measures analysis of variance (RM-ANOVA) 
RM-ANOVA can only be applied for balanced data [6]. When there is also a between 112 
group variable (e.g. treatment) the standard RM-ANOVA decomposes the total variation 
into (i) between subject variation due to treatment effect; (ii) time effect; (iii) time-and-114 
treatment effect; and (iv) the residual error variation. This can be leveraged to test different 
hypotheses, respectively: (a) an overall treatment effect; (b) differences in outcomes over 116 
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time; (c) a different effect of treatment over time. The latter derives from the interaction 
between time and treatment, which if zero would imply effects are parallel through all time 118 
points. In addition to the usual assumption imposed on ANOVA, RM-ANOVA depends on the 
assumption of sphericity. Effectively, this can be considered as being equivalent to equal 120 
variability of measurements at each time (i.e. homogeneity) and equal correlations between 
any pair of time points (e.g. corr(𝑦tim𝑒1 , 𝑦time2) ≈ ⋯ ≈ corr(𝑦time1 , 𝑦time3) for 122 
measurements 𝑦 recorded at times 1, 2, 3, …). This assumption is restrictive for longitudinal 
data, since measurements taken closely together are often more correlated than those 124 
taken at larger time intervals [7]. Violation of this assumption typically results in an inflated 
type I error rate and can bias the interaction effect [7]. If used, it is essential that this 126 
assumption is checked and reported. Typically, this is achieved through Mauchly’s epsilon 
test; however, this test is known to have low power. When sphericity is violated, there are 128 
several corrections to the degrees of freedom of the F-test that can be used [8], including 
Greenhouse-Geisser and Huynh-Feldt methods. 130 
Linear mixed models (LMMs) 
Linear mixed models are extensions of more conventional linear models. Let 𝑌𝑖𝑗 132 
denote the observed outcome measured on subject 𝑖 (𝑖 = 1, … , 𝑛) at time 𝑡𝑖𝑗 (𝑗 = 1, … , 𝑛𝑖), 
where 𝑛𝑖 is the number of measurements for subject 𝑖. By pooling the data, one can fit a 134 
linear regression model 
𝑌𝑖𝑗 = 𝛽0 + 𝛽1𝑡𝑖𝑗 + 𝜀𝑖𝑗 , 136 
where 𝜀𝑖𝑗 is a measurement error term (or residual), which allows for the outcome to 
randomly vary above or below the mean value for each time point. Here, 𝛽1 represents the 138 
population slope (Figure 1A, black line): the constant effect on the outcome corresponding 
to a one-unit increase in time. LMMs can also be fitted to unbalanced datasets with 140 
irregularly spaced time points (Figure 1B), hence each measurement time (𝑡𝑖𝑗) being 
allowed to be different between subjects in model above. Linear mixed models are 142 
predicated on the idea that each subject has their own mean response profile which 
deviates randomly from the average (overall) trajectory [9]. That is, for each subject 𝑖, we 144 
extend the model above by including a random intercept 𝑏0𝑖 and a random slope 𝑏1𝑖: 
𝑌𝑖𝑗 = (𝛽0 + 𝑏0𝑖) + (𝛽1 + 𝑏1𝑖)𝑡𝑖𝑗 + 𝜀𝑖𝑗 , 146 
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where (𝑏0𝑖 , 𝑏1𝑖) are called  subject-specific random effects, and assumed to follow a zero-
mean multivariate normal distribution and be correlated. An intuitive graphical 148 
representation of this is shown in Figure 1A. Here, 𝛽0 and 𝛽1, averaged across all subjects, 
have the same interpretation, i.e. fixed population-level intercept and slope effects, as for 150 
the simple linear regression model. The combination of fixed and random effects is why we 
refer to this model as a mixed effects model, which are also sometimes referred to as multi-152 
level models, random-effects models, random growth-curve models, etc. As well as allowing 
for subject-specific trajectories, the random effects also ensures that observations within-154 
subjects are more correlated than observations between-subjects, with the case presented 
here allowing for heterogeneity over time. In the above we assumed time was measured 156 
continuously and linearly; however, we might relax this assumption by treating time as 
measured categorically (providing the data are balanced) or through spline functions, which 158 
allow for smooth regression curves that capture nonlinearity [10]. In such cases, we can 
include additional higher-order random effects; the linear model was presented here for 160 
purposes of demonstration. LMMs can also include other adjustment covariates, including 
time-varying covariates. In particular, one might want to adjust for the baseline 162 
measurement of 𝑌 rather than treat it as an outcome at the baseline time point, i.e. before 
treatment intervention [11]. 164 
 
EXAMPLE 166 
As an example, we consider data from Grizzle and Allen [12], who describe a 
laboratory experiment that collected serial measurements of coronary sinus potassium 168 
(CSP) (mEq/L) from four groups of dogs. The groups were: 
• Control group: N=9 untreated dogs with coronary occlusion. 170 
• ECD (3-weeks) group: N=10 dogs given extrinsic cardiac denervation (ECD) 3-weeks 
prior to coronary occlusion 172 
• ECD (0-weeks) group: N=8 dogs treated similarly to above, but given ECD 
immediately prior to coronary occlusion. 174 
• Sympathectomy group: N=9 dogs treated with bilateral thoracic sympathectomy and 
stellectomy three weeks prior to coronary occlusion. 176 
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The response variable was recorded at times 1, 3, 5, 7, 9, 11, and 13 minutes. Before we 
analyse the data, we inspect the data graphically (Figure 2B), where we observe a growth-178 
like trend and substantial between-subject heterogeneity. 
If the primary scientific objective was to describe changes in CSP over the 12-minute 180 
follow-up period and determine whether the pattern of change differed between groups, 
then we could fit a linear mixed model including treatment effect and time as a continuous 182 
covariate with an interaction term to capture non-parallel growth trends. Despite Figure 2B 
indicating some non-linearity towards the end of the study follow-up, we note that we’ve 184 
made a strong assumption of linearity in this example. Fitting this model (Table 2) indicates 
that there is a significant increase in CSP during follow-up in the control group (i.e. a 186 
significant effect for time; 0.08 [95% CI: 0.05 to 0.12]), and no discernible difference from 
this trend in group ECD (0-weeks) (i.e. non-significant interaction term with time; -0.02 [95% 188 
CI: -0.08 to 0.03]). The ECD (3-weeks) group interaction term is significant (P<0.001), and 
despite not reaching significance, there was a tendency for CSP to be reduced over time in 190 
sympathectomy group (-0.05; 95% CI: -0.10 to 0.00). Moreover, both terms are negative, 
which is consistent with Figure 2B where the time course for these two groups are relatively 192 
flat. We could formally test this using appropriate contrasts. One could also perform post 
hoc tests to establish treatment effect differences at each measurement time (Figure 2A), 194 
but one would need to correct for multiple comparisons (not implemented here). Neither 
group admitted a significant main treatment effect relative to the control group. Code to fit 196 
this model using the R statistical software package are shown in the Appendix. 
Since the data are consistent with a linear growth-like pattern, one might consider 198 
comparing a summary statistic approach. For example, a comparison of the slopes (see 
Table S2) would reveal whether there was a significant difference in the rate of change in 200 
CSP between groups. A Kruskal-Wallis test applied to the 4-groups of slopes suggests a 
significant difference (Table 2, Figure 2C), with the median slopes (first, third quartiles) 202 
being 0.098 (0.086, 0.104), -0.003 (-0.012, -0.002), 0.054 (0.024, 0.125), and -0.009 (-0.021 
to 0.089) in the control, ECD (3-weeks), ECD (0-weeks), and sympathectomy groups, 204 
respectively. 
 206 
DISCUSSION 
 8 
Despite RM-ANOVA being a common choice for analysing repeated measures in the 208 
EJCTS and ICVTS, there are many alternative approaches. Linear mixed models represent the 
most sophisticated of the models discussed, and are more amenable to real-world clinical 210 
data as opposed to highly controlled experimental study designs. Hence, there have been 
calls for some time to abandon less versatile methods [7]. The integration of these model 212 
fitting methods into routine statistical software therefore removes a major barrier to 
applied researchers. Moreover, one can extend mixed models to incorporate more flexible 214 
correlation structures [13], non-continuous outcomes (e.g. binary), and non-linear 
outcomes [14], In some cases, there might be multivariate longitudinal data (multiple 216 
repeated measures outcomes), which may even be correlated with a time-to-event 
outcome, giving rise to so-called joint models [9,15]. On the other hand, two-stage 218 
approaches offer a simpler—both mathematically and intuitively—approach that can 
provide insight into data profiles and complement more rigorous modelling approaches. We 220 
only addressed a subset of the methodological tools available. Other such methods have not 
been discussed here, including generalised estimating equations, MANOVA [7], generalised 222 
least squares [10], and empirical Bayes [8]. 
Despite repeated measures data being routinely collected at follow-up, particularly 224 
in long-term observational studies, the situation of only analysing baseline (preoperative) 
and a single postoperative value—typically the last follow-up measurement—remains 226 
commonplace in the EJCTS and ICVTS, even though this may not be the most appropriate 
method. Whatever the choice of methodology employed, it is essential that the data, study 228 
design, methods, supporting assumptions, and any post hoc analyses are well described and 
justified to facilitate reproducibility, to provide opportunity for readers to critique the 230 
analysis [16], and to avoid misinterpretation due to overlapping terminology [8]. Graphs are 
a highly effective way of summarising and presenting repeated measures data; however, it 232 
is essential that they are presented on common axes scales, appropriately summarised and 
described (e.g. defining any error bars) [4]. Nonetheless, figures such as those shown in 234 
Figure 2A should be avoided. It is important to consider distributional assumptions (e.g. 
normality in the RM-ANOVA) or that the growth-curve is approximately linear if calculating 236 
it as a summary measure. When these assumptions are violated, transformations or 
alternative models might be considered. In addition, we recommend more thought is given 238 
to sample size determination during study design [17]. 
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FIGURE LEGENDS 298 
 
Figure 1. Panel A: a graphical representation of a linear mixed effects model. The mean 300 
trajectories of two hypothetical patients (A and B; coloured lines) and the mean trajectory 
averaged over the complete sample of patients (black line) are shown. Panel B: longitudinal 302 
study dataset exploring the long-term profile of rate of left ventricular mass regression with 
time after aortic valve replacement with a stentless or a homograft valve. Smoothed lines 304 
represent average profiles stratified by valve type, estimated using the LOESS method. Data 
originally analysed in Lim et al. [19]. 306 
 
Figure 2. Panel A: a so-called ‘dynamite plot’ showing the mean (height of bars) longitudinal 308 
measurement values for different treatment groups at each measurement time, together 
with the standard deviation (SD; error bar: ± 1 SD). Kruskal Wallis rank-sum tests comparing 310 
the outcome between the four treatment groups: # = P<0.1, * = P<0.05, ** = P<0.01, *** = 
P<0.001. Panel B: serial measurements of coronary sinus potassium (CSP) (mEq/L) from four 312 
groups of dogs. Each translucent line represents a single dog, whilst line colours denote 
treatment group. Mean profiles (bold lines) are overlaid to summarise the average group 314 
trajectories. Panel C: a graphical display of the summary statistic slopes method, estimated 
by fitting separate linear regression lines to each dog (cf. Panel A) and extracting the 316 
estimated slopes. The slopes for each treatment group are summarised here as boxplots. 
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Table 1. Methodologies for analysing repeated measures data, their advantages and disadvantages, and some software options. 318 
Method Advantages Disadvantages Software 
Two-stage 
methods 
• Analysis is based on familiar univariate 
analysis methods 
• Data summary methods may facilitate 
interpretation, e.g. AUC and rate of 
change are well-understood concepts in 
biomedicine research 
• Multiple summary methods can be used 
• Can be difficult to specify the correct 
summary statistic in advance 
• Reduced data summary statistics are 
relatively less efficient 
• Reduced data summary statistics can lose 
information or fail to capture features of 
the time course 
• Summary methods not readily 
implemented in statistical software, but 
the summary measures are generally 
rudimentary to calculate 
• Missing data can result in sample bias 
• Standard tests for independent groups 
(e.g. t-test, ANOVA, Mann-Whitney U-test, 
Kruskal-Wallis test) are standard in all 
statistics software packages 
• Summary statistics can be calculated ‘by 
hand’ or using a simple programme 
written in a spreadsheet or statistics 
package 
RM-
ANOVA 
• Includes the data at all time points 
• Simple to implement, and conceptually an 
extension of the ubiquitous ANOVA 
• Requires complete data on each subject 
• Depends on restrictive sphericity 
assumption, which is highly questionable 
for longitudinal data 
• Cannot handle mistimed / unbalanced 
measurements 
• Results provide limited information on 
how the groups differ, often requiring post 
hoc analyses 
• SPSS: ‘General Linear Model: Repeated 
Measures’ 
• SAS: PROC GLM 
• R: aov, Anova (in the car1 package), 
ezANOVA (in the ez2 package) 
• Stata: anova 
LMMs • Includes the data at all time points 
• Missing data can be straightforwardly 
handled if missing (completely) at random 
• Allows flexible modelling of the time effect 
• Implementation and complexity of fitting 
is relatively more difficult 
• Assumptions can be harder to assess 
• SPSS: ‘Mixed Models’ 
• SAS: PROC MIXED 
• R: lme (nlme3 package) or lmer (lme44 
package) 
                                                      
1 Fox J, Weisberg S (2011). An R Companion to Applied Regression, Second Edition. Thousand Oaks CA: Sage. 
2 Lawrence MA (2016). ez: Easy Analysis and Visualization of Factorial Experiments. R package version 4.4-0. https://CRAN.R-project.org/package=ez 
3 Pinheiro JC, Bates DM (2000). Mixed-Effects Models in S and S-PLUS. New York: Springer Verlag. 
4 Bates D, Maechler M, Bolker B, Walker S (2015). Fitting Linear Mixed-Effects Models Using lme4. Journal of Statistical Software, 67(1), 1-48. 
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• Permits unbalanced data with greatly 
different numbers of measurements per 
subject 
• Allows for time-varying covariates 
• Permits estimation of individual trends 
• Can be augmented with more complex 
covariance structures that captures more 
features of the correlation patterns, and 
hierarchically 
• Stata: xtmixed 
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Table 2. Results from analysis of laboratory experiment longitudinal data. 320 
Linear mixed effects modela 
 Estimate SE 95% CI P 
Intercept 4.05 0.17 (3.72 to 4.37) <0.001 
Group     
    ECD (3-weeks) -0.44 0.23 (-0.90 to 0.03) 0.064 
    ECD (0-weeks) -0.33 0.24 (-0.82 to 0.17) 0.19 
    Sympathectomy -0.32 0.23 (-0.80 to 0.15) 0.18 
Time (mins) 0.08 0.02 (0.05 to 0.12) <0.001 
Time * ECD (3-weeks) -0.09 0.03 (-0.14 to -0.04) <0.001 
Time * ECD (0-weeks) -0.02 0.03 (-0.08 to 0.03) 0.43 
Time * Sympathectomy -0.05 0.03 (-0.10 to 0.00) 0.054 
Summary statistic (Kruskal-Wallis rank-sum tests) 
 df 𝝌𝟐 P 
Slope 3 8.53 0.036 
Final value 3 11.14 0.011 
Notation: CSP–coronary sinus potassium; SE–standard error; CI–confidence interval; ECD–
extrinsic cardiac denervation; df–degrees of freedom; 𝜒2–chi-square statistic. 322 
a Fitted by restricted maximum likelihood. 
